Literature DB >> 15536166

The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II.

Axel Pflueger1, Anthony J Croatt, Timothy E Peterson, Leslie A Smith, Livius V d'Uscio, Zvonimir S Katusic, Karl A Nath.   

Abstract

ANG II induces vasoconstriction, at least in part, by stimulating NADPH oxidase and generating reactive oxygen species. ANG II also induces heme oxygenase activity, and bilirubin, a product of such activity, possesses antioxidant properties. We hypothesized that bilirubin, because of its antioxidant properties, may reduce the pressor and prooxidant effects of ANG II. Our in vivo studies used the hyperbilirubinemic Gunn rat which is deficient in the enzyme uridine diphosphate glucuronosyl transferase, the latter enabling the excretion of bilirubin into bile. ANG II (0.5 mg x kg(-1) x day(-1)) or saline vehicle was administered by osmotic minipump to control and Gunn rats for 4 wk. The rise in systolic blood pressure induced by ANG II, as observed in control rats, was markedly reduced in Gunn rats, the latter approximately 50% less at 3 and 4 wk after the initiation of ANG II infusion. The chronic administration of ANG II also impaired endothelium-dependent relaxation responses in control rats but not in Gunn rats. As assessed by the tetrahydrobiopterin/dihydrobiopterin ratio, ANG II induced oxidative stress in the aorta in control rats but not in Gunn rats. Heightened generation of superoxide anion in aortic rings in ANG II-infused rats and by vascular smooth muscle cells exposed to ANG II was normalized by bilirubin in vitro. We conclude that the pressor and prooxidant effects of ANG II are attenuated in the hyperbilirubinemic Gunn rat, an effect which, we speculate, may reflect, at least in part, the scavenging of superoxide anion by bilirubin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536166     DOI: 10.1152/ajprenal.00278.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  40 in total

Review 1.  Heme oxygenase, a novel target for the treatment of hypertension and obesity?

Authors:  Peter A Hosick; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction.

Authors:  Vesna Stojanović; Tamara Vukavić
Journal:  Indian J Pediatr       Date:  2011-01-04       Impact factor: 1.967

3.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction: a story.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

Review 4.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo.

Authors:  Hong Wang; Jeffrey L Garvin; Martin A D'Ambrosio; John R Falck; Pablo Leung; Ruisheng Liu; YiLin Ren; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

6.  Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat.

Authors:  Noha N Nassar; Guichu Li; Aurel L Strat; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2011-07-18       Impact factor: 4.030

7.  Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility.

Authors:  N Hassan; H M El-Bassossy; M N M Zakaria
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-20       Impact factor: 3.000

Review 8.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

9.  Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice.

Authors:  Trinity Vera; Joey P Granger; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-01       Impact factor: 3.619

10.  Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress.

Authors:  Jian Cao; George Drummond; Kazuyoshi Inoue; Komal Sodhi; Xiao Ying Li; Shinji Omura
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.